# A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148)

> **NCT00819039** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 98 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Ondansetron

## Key facts

- **NCT ID:** NCT00819039
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-26
- **Primary completion:** 2013-03-12
- **Final completion:** 2013-03-12
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2021-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00819039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00819039, "A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148)". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT00819039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*